Anthera Pharmaceuticals (ANTH) Cuts 45% of Workforce After Termination of VISTA-16 Study
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Join SI Premium – FREE
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) provided an update on company events following the recent termination of the VISTA-16 clinical study.
Immediately after the VISTA-16 Data Safety Monitoring Board (DSMB) recommended halting the clinical study, the Company took steps to cease patient enrollment and dosing. Redundant levels of written communication were sent to the investigators and clinical sites involved in the study to immediately cease enrollment and to withdraw all enrolled patients. The Company will be conducting final patient follow-up visits within the coming weeks.
The Company has taken immediate action to decrease operating expenses through a reduction or elimination of vendor activities and immediate headcount reductions. This will result in an elimination of approximately 45% of Anthera's headcount. These combined actions allow for the reallocation of resources to other potential development programs and product portfolio efforts.
Immediately after the VISTA-16 Data Safety Monitoring Board (DSMB) recommended halting the clinical study, the Company took steps to cease patient enrollment and dosing. Redundant levels of written communication were sent to the investigators and clinical sites involved in the study to immediately cease enrollment and to withdraw all enrolled patients. The Company will be conducting final patient follow-up visits within the coming weeks.
The Company has taken immediate action to decrease operating expenses through a reduction or elimination of vendor activities and immediate headcount reductions. This will result in an elimination of approximately 45% of Anthera's headcount. These combined actions allow for the reallocation of resources to other potential development programs and product portfolio efforts.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FingerMotion CEO outlines AI computing expansion in North America
- Grand Canyon Education places CFO on leave amid stock trade probe
- Trident Digital Tech Holdings (TDTH) files $200M mixed shelf
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
